20 July 2021

We are 10 million steps closer to finding the causes, better treatments, and even a cure for neurological conditions.

We have 10 million reasons to give people hope.

Because this year, MSWA is investing a record-breaking $10 million into neurological research.

Over the last decade, our commitment to research has resulted in MSWA investing more than $20 million in funding, making us the leading contributor to neurological research in Western Australia.

Today, MSWA is proud to announce that in this 2021/22 financial year, we are committing a record-breaking amount of $10 million to neurological research.

This new $10 million contribution is being used by recipients to advance studies to clinical trials for new treatments and medications, develop and trial new apps and educational tools, and provide novel insights that add to the knowledge of the wider neurological research community.

Marcus Stafford AM, MSWA CEO said of the announcement, “As we prepare to celebrate our champions in the forthcoming Olympic Games, supporters of MSWA should feel proud to take their place on the podium. MSWA’s $10 million contribution to research is a gold medal winning achievement for people with neurological conditions. In fact, I am delighted to say that this record-breaking contribution to research makes MSWA the largest non-government funder of neurological research in Australia.”

While we contribute funding for projects and studies across Australia and the world, we are particularly proud of the ongoing support of neurological research taking place in Western Australia. By supporting local institutions and experts, we are making research developments accessible to our community, and providing opportunities for Western Australia to become a hub for high quality research.

“Without MSWA’s funding I would have to consider going interstate,” said long-term MSWA funding recipient, Associate Professor Lucinda Black from Curtin University who investigates the links between multiple sclerosis and diet.

Creating real life-changing outcomes for people living with neurological conditions, the vital research we fund is delivering medical and therapeutic breakthroughs. With our priority on innovation and gaining much needed insights, MSWA is cultivating a rich network of scientific researchers willing to make a difference.

We are pleased to once again be partnering with MS Australia, the International Progressive MS Alliance, the Perron Institute, Curtin University, Edith Cowan University, and Telethon Kids Institute in projects they are leading across various neurological research areas.

Associate Professor Desmond Graham, President of MS Australia, said, “This funding commitment from MSWA is significant, and on behalf of MS Australia, the MS community and myself as a person living with MS, I would like to thank the MSWA Board and CEO Marcus Stafford.

“This funding boost will assist to supercharge MS research in Australia, some great examples of which occur in WA. It will accelerate the world leading work of our MS researchers, enabling them to identify new treatments for people living with MS, in particular those with the progressive forms of the disease, as well as investigate ways to enhance the brain’s defences against MS and repair myelin.”

The Perron Institute’s CEO Steve Arnott said, "MSWA’s funding means our researchers can continue striving to find novel treatments for people living with a range of neurological conditions.

"Their support is also helping the Perron Institute to expand its work with both new and existing programs and increase its achievements within various research streams."

Our commitment to research helps us get one step closer to having a better understanding of the causes of neurological conditions, finding new treatments, realising potential cures, and providing hope for people living with neurological conditions.

As always, our contribution is only made possible through the incredible support of our fundraising community. Together, we are ready to make an impact.

To read more about the projects we are funding, visit our Commitment to Research page.